Trials / Completed
CompletedNCT00523601
Quetiapine Efficacy in Bipolar Depression Study
A 8-Week, Multicenter, Open-Label, Observational Study of the Efficacy of Quetiapine Fumarate (SEROQUEL) Immediate-Release Tablets in Adult Patients With Bipolar Depression
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,000 (estimated)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
To reassure the clinical study data on Seroquel antidepressant efficacy in patients who are diagnosed as bipolar depression
Conditions
Timeline
- Start date
- 2007-06-01
- Primary completion
- 2007-10-01
- Completion
- 2007-12-01
- First posted
- 2007-08-31
- Last updated
- 2008-10-06
Locations
3 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT00523601. Inclusion in this directory is not an endorsement.